Additional file 15 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder

Additional file 15. Table S3: Differentially expressed mRNAs, proteins, and phosphoproteins between tumors and MNUs. Related to Figure 3, Additional file 3: Fig. S3. A. Lists of mRNAs, proteins, and phosphoproteins used for principal component analysis (PCA). B. Lists of differentially expressed mRNAs, proteins and phosphoproteins (Wilcoxon rank-sum test, FDR < 0.01, Tumors/MNUs ratio > 2 or < 1/2) in tumors and MNUs. C. A list of genes with significant patient survival difference on both protein and mRNA level. D. A list of candidate target genes of UC.